Pacific Biosciences of California, Inc. (PACB)
1.955
-0.02
(-0.76%)
USD |
NASDAQ |
Nov 13, 16:00
1.955
0.00 (0.00%)
After-Hours: 17:07
Pacific Biosciences of California Enterprise Value : 1.121B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.121B |
| November 11, 2026 | 1.158B |
| November 10, 2026 | 1.205B |
| November 09, 2026 | 1.243B |
| November 06, 2026 | 1.210B |
| November 05, 2026 | 1.265B |
| November 04, 2026 | 1.302B |
| November 03, 2026 | 1.268B |
| November 02, 2026 | 1.238B |
| October 30, 2026 | 1.319B |
| October 29, 2026 | 1.411B |
| October 28, 2026 | 1.390B |
| October 27, 2026 | 1.271B |
| October 26, 2026 | 1.208B |
| October 23, 2026 | 1.165B |
| October 22, 2026 | 1.149B |
| October 21, 2026 | 1.174B |
| October 20, 2026 | 1.118B |
| October 19, 2026 | 1.080B |
| October 16, 2026 | 1.046B |
| October 15, 2026 | 1.118B |
| October 14, 2026 | 1.127B |
| October 13, 2026 | 1.146B |
| October 12, 2026 | 1.162B |
| October 09, 2026 | 1.233B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.224B |
| October 07, 2026 | 1.355B |
| October 06, 2026 | 1.349B |
| October 05, 2026 | 1.402B |
| October 02, 2026 | 1.299B |
| October 01, 2026 | 1.290B |
| September 30, 2026 | 1.246B |
| September 29, 2026 | 1.038B |
| September 28, 2026 | 1.001B |
| September 25, 2026 | 972.73M |
| September 24, 2026 | 960.30M |
| September 23, 2026 | 907.46M |
| September 22, 2026 | 926.11M |
| September 21, 2026 | 891.92M |
| September 18, 2026 | 895.03M |
| September 17, 2026 | 898.14M |
| September 16, 2026 | 885.71M |
| September 15, 2026 | 885.71M |
| September 14, 2026 | 888.81M |
| September 11, 2026 | 873.27M |
| September 10, 2026 | 863.95M |
| September 09, 2026 | 870.17M |
| September 08, 2026 | 879.49M |
| September 04, 2026 | 888.81M |
| September 03, 2026 | 873.27M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Illumina, Inc. | 32.83B |
| Danaher Corp. | 185.41B |
| Thermo Fisher Scientific, Inc. | 294.59B |
| Agilent Technologies, Inc. | 50.97B |
| Bio-Rad Laboratories, Inc. | 9.660B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -37.85M |
| Revenue (Quarterly) | 40.56M |
| Total Expenses (Quarterly) | 78.41M |
| EPS Diluted (Quarterly) | -0.1216 |
| Gross Profit Margin (Quarterly) | 31.89% |
| Profit Margin (Quarterly) | -93.30% |
| Earnings Yield | -21.81% |
| Normalized Earnings Yield | -19.63 |